Clinical trials - Press Releases

Date	Title	Company
23-Mar-2020	ISA Pharma publishes phase 2 study data in major peer-reviewed journal	ISA Pharmaceuticals
23-Mar-2020	NDA Group tackles increased regulatory complexity for Medical Device manufacturers through new division	NDA Group
23-Mar-2020	Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study	Ergomed plc
23-Mar-2020	Britain’s fastest-growing privately-owned pharma companies revealed	Alantra
23-Mar-2020	Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma	Eureka Therapeutics
23-Mar-2020	Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa	eona Therapeutics
23-Mar-2020	Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine	Pfizer
23-Mar-2020	Statement on COVID-19 from the European Cancer Organisation’s Board of Directors: ‘Attention is urgently required to protect cancer patients and preserve Europe’s healthcare professional, scientific and patient societies’	Board of Directors of the European Cancer Organisation
23-Mar-2020	Haselmeier Receives Medical Device Master File Number for D-Flex Product Platform	Haselmeier
23-Mar-2020	4D pharma presents additional interim clinical data from combination study for lead oncology candidate	4D
23-Mar-2020	Vectura Group plc: 2019 Preliminary Results	Vectura Group plc
23-Mar-2020	Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine	Pfizer
23-Mar-2020	Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates	Abeona Therapeutics
23-Mar-2020	Inceptua announces global license agreement for the commercialization of JETREA®	Inceptua
20-Mar-2020	EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy announce initiation of an observational case-control study of siltuximab in patients with COVID-19 who have developed serious respiratory complications	EUSA Pharma
19-Mar-2020	Albumedix Announces CBER FDA Drug Master File Acceptance for Recombumin® Elite and Appointment of Director of Regulatory Affairs	Albumedix Ltd
16-Mar-2020	TIKOMED Secures 5M Euro Funding for the Clinical Development of ILB™ and IBSOLVMIR®	TIKOMED
16-Mar-2020	BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat	BioNTech
16-Mar-2020	GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX®, (cannabidiol) oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex (TSC)	GW Pharmaceuticals plc
16-Mar-2020	Are kidneys targeted by the novel coronavirus?	ERA-EDTA